Long Term Safety Study of Tanezumab in Chronic Low Back Pain
This study has been terminated.
(See termination reason in detailed description.)
First Posted: June 19, 2009
Last Update Posted: August 30, 2012
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||November 2010|
|Primary Completion Date:||November 2010 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Submission:||January 27, 2012|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Hochberg MC, Tive LA, Abramson SB, Vignon E, Verburg KM, West CR, Smith MD, Hungerford DS. When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program. Arthritis Rheumatol. 2016 Feb;68(2):382-91. doi: 10.1002/art.39492.